North up wide sales TOP10 out! Qilu, stone medicine, Yangzijiang... On the list, Bolivi, Bai Tangyan fell to the altar

North to Guangzhou, not only the main rich cities in China, but also the domestic drug sales "big households."
meters of intranet data show that in the 2020H1 key city public hospital drug city pattern, the north to Guangzhou three cities of drug sales are still in the top three, but the ranking has changed.
New crown outbreak superimposed on the impact of medical reform policy, north of the three cities brand TOP10 although ups and downs, but anti-tumor drugs still dominate the market; Domestic brands are on the list.
2020H1 Beijing, Shanghai, Guangzhou public hospital terminal chemical city pattern source: key city public hospital chemical terminal competition pattern Beijing: Bo Liwei, Bai Tangping fell "the altar"! China Resources Shuanghe unique Beijing public hospital terminal chemical drug annual sales trend (units: 100 million yuan) Source: Key city public hospitals chemical terminal competition pattern Mi net data show that 2020H1 Beijing public hospital terminal chemical drug sales fell by more than 20% YoY, the most significant decline in the three major cities.
from the therapeutic field, the sales of TOP3 categories are anti-tumor and immunomodulants, digestive and metabolic drugs, systemic anti-infective drugs, accounting for 21.4%, 14.34% and 13.45% respectively.
2020H1 Beijing public hospital terminal chemical brand TOP10 Source: Key city public hospital chemical terminal competition pattern in Beijing public hospital terminal chemical drug brand TOP10, anti-tumor drugs have 3, whole-body anti-bacterial drugs, blood substitutes and perfusion fluids, blood lipid regulators have 2 each.
Roche's three major mono-resistances, Melohua (lytoxi-mono-resistance) was first absent from bio-similar drugs, the first lyxi monobial-like drug (Hanlicon) was approved in February 2019, and the second was recently spent on Cynda Bio.
AstraZeneta's lung cancer star drug, OxyDinist, won the top sales with strong growth, with sales at 2020H1 up 97.18 per cent year-on-year.
Terisha is the world's first target drug for third-generation advanced lung cancer, with a 70 percent price cut in 2018 and the approval of first-line therapies in 2019 driving a surge in sales.
Pfizer's Lipto (Atovastatin calcium tablets) came in second, with sales of 2020H1 down 31.27 percent year-on-year, and Sanofi's Polyvi (hydrochlorochlorogre tablets sulphate) dropping out of the brand TOP10, with sales of 2020H1 down 53.65 percent year-on-year.
Bayer's Bertang (Akapo sugar flakes) is nowhere to be seen, but Bairetto (Devassaban tablets) is doing well.
double crane's Pivastatin calcium tablets are the only domestic brands on the list.
pivastatin calcium tablets for blood lipid regulators, the first batch of collection catalog will be atovastatin, Ruishuvastatin included, the two statin prices of the "diving" so that pivastatin ushered in market development opportunities.
the market will shrink in the future as pivastatin enters its third collection.
: This anti-thrombosis drug is great! Yangzijiang, Sansheng on the list of Shanghai public hospitals terminal chemical drugs annual sales trends (units: 100 million yuan) Source: key cities public hospitals chemical terminal competition pattern of mi-net data show that 2020H1 Shanghai public hospital terminal chemicals sales fell by more than 5% YoY, the smallest decline in the three major cities.
from the therapeutic field, the sales of TOP3 categories are anti-tumor and immunomodulants, digestive and metabolic drugs, systemic anti-infective drugs, accounting for 23.96 percent, 14.69 percent, 14.69 percent.
2020H1 Shanghai public hospital terminal chemical drug brand TOP10 Source: Key city public hospital chemical terminal competition pattern in Shanghai public hospital terminal chemical drug brand TOP10, anti-tumor drugs have 5, plasma substitutes and infusions have 2, anti-thrombosis drugs, painkillers, immunosuppressants have 1 each.
it is worth mentioning that the national collection varieties this time no one on the list.
Roche's three major single-anti-lysioxine (lyxi monoanti) and Hercetin (curto-bead monoanti) and Anvetin (beva-bead monoanti) were among the best, although sales declined, and Gelifu's hemoglobin ranking rose to TOP2, with the prevention and treatment of albumin in the new crown outbreak driving sales growth.
Bayer's Berrito (Devassaban tablet) performed surprisingly well, with sales of 2020H1 up 75.26% year-on-year.
Devasalban tablets in the domestic anti-thrombosis drug market ranked second, "anti-thrombosis one brother" clopidogre included in the collection, Devasalban showed great help.
is also of concern that the devasalban compound patent expires in December 2020 and faces the impact of generics and harvesting.
domestic brands on the list are Yangzijiang Pharmaceutical Group's Tyzosin Injection, Sansheng Pharmaceuticals' Tebio (recombinant human platelet-producing injections).
Sansheng Pharmaceuticals semi-annual report shows that Tybe Australia 2020H1 sales of 1.375 billion yuan, an increase of 15.2% year-on-year, due to the inelastic medical needs of patients, its sales are less affected by the new crown outbreak.
: collection of varieties sales jumped 124%! Stone medicine, Qilu on the list of Guangzhou public hospitals terminal chemical drugs annual sales trend (units: 100 million yuan) Source: key city public hospitals chemical terminal competition pattern Mi net data show that 2020H1 Guangzhou public hospital terminal chemicals sales fell by more than 10% YoY.
from the therapeutic field, the sales of TOP3 categories are anti-tumor and immunomodulating agents, digestive and metabolic drugs, blood and hematopoies drugs, accounting for 30.84 percent, 13.85 percent and 12.38 percent, respectively.
2020H1 Guangzhou public hospital terminal chemical brand TOP10 Source: Key city public hospital chemical terminal competition pattern in the first half of 2020 by the new crown epidemic, hospital outpatient volume decreased significantly, but anti-tumor drugs and other strong just need drugs are less affected.
in Guangzhou city public hospital terminal chemical brand TOP10, anti-tumor drugs have 7 brands on the list, the remaining 3 brands belong to immunostululants, whole-body anti-bacterial drugs, anti-hemostic drugs.
AstraZene Cazorlan's Ogini again took the top of the sales, with sales up 97.05 per cent year-on-year.
and the most outstanding performance is the stone drug Ouyi's keael (injection with yew alcohol albumin binding type), 2020H1 sales increased by 124.11 percent year-on-year, becoming the injection of yew alcohol lipids that were squeezed out of the previous period.
injection with yew alcohol (albumin binding type) for the second batch of collecting varieties, stone drug Euroi winning the bid and responsible for the supply of the drug in Guangdong Province.
's domestic brands on the list are in addition to the stone drug Ouyi's Ke Ai, as well as Qilu Pharmaceutical's new Ruibai (polyglycol recombinant human granulocyte stimulation factor injection), Shi medicine Eugene's polymethycin (hydrochloric acid dolubie lipid body injection).
semi-annual report of The Rock Pharmaceutical Group showed that the sales revenue of K-Aly and Domein increased by 70.9% and 23.7% year-on-year.
.